MEIP Dec 2024 4.000 call
| Previous close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.0000 |
| Ask | 4.5000 |
| Strike | 4.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.5000 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 40 |
Business WireMEI Pharma Reports Fiscal Year End 2024 Cash Position
SAN DIEGO, September 19, 2024--MEI Pharma, Inc. (Nasdaq: MEIP) (the "Company") today reported results for its fiscal year ended June 30, 2024.
- Business Wire
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
SAN DIEGO, August 12, 2024--MEI Pharma, Inc. (Nasdaq: MEIP) (the "Company") today announced that it has engaged Oppenheimer & Co. Inc. to serve as the Company’s exclusive financial advisor to assist in its previously announced process to review and evaluate strategic alternatives. The Company remains focused on maximizing the value of its assets for its stockholders.
- Business Wire
MEI Pharma to Consider Strategic Alternatives
SAN DIEGO, July 22, 2024--MEI Pharma, Inc. (Nasdaq: MEIP) (the "Company") today announced that its Board of Directors has determined unanimously to begin evaluation of the Company’s strategic alternatives, including potential transactions as well as an orderly wind down of the Company, if appropriate, in order to maximize the value of its assets for its stockholders. The Company intends to evaluate and engage a financial advisor to assist in this process.
